Author:
Probert Philip M.,Leitch Alistair C.,Dunn Michael P.,Meyer Stephanie K.,Palmer Jeremy M.,Abdelghany Tarek M.,Lakey Anne F.,Cooke Martin P.,Talbot Helen,Wills Corinne,McFarlane William,Blake Lynsay I.,Rosenmai Anna K.,Oskarsson Agneta,Figueiredo Rodrigo,Wilson Colin,Kass George E.,Jones David E.,Blain Peter G.,Wright Matthew C.
Funder
Newcastle University
National Institute for Health Research Health Protection Research Unit
PHE
Newton-Mosharafa Fund
LIVErNORTH
NIHR
HPRU
Reference67 articles.
1. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis;Williams;Lancet,2014
2. http://www.bsg.org.uk/clinical/commissioning-report/management-of-patients-with-chronic-liver-diseases.html.
3. Novel therapeutic targets in primary biliary cirrhosis;Dyson;Nat Rev Gastroenterol. Hepatol.,2015
4. HLA class II alleles, genotypes, haplotypes and amino acids in primary biliary cirrhosis: a large-scale study;Donaldson;Hepatology,2006
5. Dawwas MF; UK PBC Consortium.; Wellcome Trust Case Control Consortium 3, Jones DE, Peltonen L, Alexander GJ, Sandford RN, Anderson CA. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis;Mells;Nat Genet.,2011